[Advances in prediction and diagnostic biomarkers on acute graft-versus-host disease after allogeneic stem cell transplantation].
作者信息
Wang Ziwei, Wang Jianmin
机构信息
Institute of Hematology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2015 Feb;36(2):172-6. doi: 10.3760/cma.j.issn.0253-2727.2015.02.021.
Abstract
摘要
相似文献
1
[Advances in prediction and diagnostic biomarkers on acute graft-versus-host disease after allogeneic stem cell transplantation].
Zhonghua Xue Ye Xue Za Zhi. 2015 Feb;36(2):172-6. doi: 10.3760/cma.j.issn.0253-2727.2015.02.021.
2
[Advances of Diagnostic Biomarkers on Acute Graft Versus Host Disease -Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):281-285. doi: 10.7534/j.issn.1009-2137.2017.01.051.
3
Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation.
Blood Cells Mol Dis. 2019 Feb;74:5-12. doi: 10.1016/j.bcmd.2018.10.001. Epub 2018 Oct 4.
4
The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
Iran J Allergy Asthma Immunol. 2012 Mar;11(1):15-21.
5
[Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (Ⅲ) -acute graft-versus-host disease (2020)].
Zhonghua Xue Ye Xue Za Zhi. 2020 Jul 14;41(7):529-536. doi: 10.3760/cma.j.issn.0253-2727.2020.07.001.
6
Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant.
J Oncol Pharm Pract. 2017 Jun;23(4):255-263. doi: 10.1177/1078155216637216. Epub 2016 Mar 11.
7
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
J Med Case Rep. 2016 Jul 28;10:209. doi: 10.1186/s13256-016-0999-z.
8
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
Haematologica. 2016 Nov;101(11):1417-1425. doi: 10.3324/haematol.2016.149294. Epub 2016 Aug 4.
9
Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease.
Clin Gastroenterol Hepatol. 2018 Jun;16(6):908-917.e2. doi: 10.1016/j.cgh.2017.12.024. Epub 2017 Dec 16.
10
Differential microRNAs expression in acute graft-versus-host disease as potential diagnostic biomarkers.
Bone Marrow Transplant. 2020 Dec;55(12):2339-2342. doi: 10.1038/s41409-020-0949-7. Epub 2020 May 13.
本文引用的文献
1
Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Transpl Infect Dis. 2014 Jun;16(3):440-9. doi: 10.1111/tid.12229. Epub 2014 May 9.
2
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.
Blood. 2014 Jul 10;124(2):287-95. doi: 10.1182/blood-2014-01-550566. Epub 2014 May 5.
3
Relative defects in mucosal immunity predict acute graft-versus-host disease.
Biol Blood Marrow Transplant. 2014 Jul;20(7):1056-9. doi: 10.1016/j.bbmt.2014.03.012. Epub 2014 Mar 15.
4
Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning.
Int J Hematol. 2014 Apr;99(4):463-70. doi: 10.1007/s12185-014-1542-x. Epub 2014 Mar 6.
5
Pretransplant C-reactive protein as A prognostic marker in allogeneic stem cell transplantation.
Scand J Immunol. 2014 Mar;79(3):206-13. doi: 10.1111/sji.12137.
6
Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
Blood. 2013 Nov 7;122(19):3365-75. doi: 10.1182/blood-2013-06-510586. Epub 2013 Sep 16.
7
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation.
Leukemia. 2014 Apr;28(4):842-52. doi: 10.1038/leu.2013.210. Epub 2013 Jul 11.
8
Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantation.
PLoS One. 2013;8(3):e58735. doi: 10.1371/journal.pone.0058735. Epub 2013 Mar 7.
9
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation.
Blood. 2012 Nov 22;120(22):4443-4. doi: 10.1182/blood-2012-08-447326.
10
Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD.
Bone Marrow Transplant. 2013 Jun;48(6):859-64. doi: 10.1038/bmt.2012.232. Epub 2012 Nov 19.
Zotero 插件